The dimension of preventable stroke in a large representative patient cohort
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective To analyze the frequency of inadequately treated risk factors in a large representative cohort of patients with acute ischemic stroke or TIA and to estimate the proportion of events potentially avertable by guideline-compliant preventive therapy compared to the status quo.
Methods A total of 1,730 patients from the Poststroke Disease Management STROKE-CARD trial (NCT02156778) were recruited between 2014 and 2017. We focused on 8 risk conditions amenable to drug therapy and 3 lifestyle risk behaviors and assessed pre-event risk factor control in retrospect.
Results The proportion of patients with at least 1 inadequately treated risk condition was 79.5% (95% confidence interval [CI] 77.6%–81.4%) and increased to 95.1% (95% CI 94.1%–96.1%) upon consideration of the lifestyle risk behaviors. Risk factor control was worse in patients with recurrent vs first-ever events (p < 0.001), men vs women (p = 0.003), and patients ≤75 vs >75 years of age (p < 0.001). The estimated degree of stroke preventability ranged from 0.4% (95% CI 0.2%–0.6%) to 13.7% (95% CI 12.2%–15.2%) for the individual risk factors. Adequate control of the 5 most relevant risk factors combined (hypertension, hypercholesterolemia, atrial fibrillation, smoking, and overweight) would have averted ≈1 of 2 events or 1 in 4 with a highly conservative computation approach.
Conclusions Our study confirms the existence of a considerable gap between risk factor control recommended by guidelines and real-world stroke prevention. Our study intends to increase awareness among physicians about stroke preventability and provides a quantitative basis for the emerging discussion on how to best tackle this challenge.
Glossary
- ASCVD=
- atherosclerotic cardiovascular disease;
- AF=
- atrial fibrillation;
- BMI=
- body mass index;
- CI=
- confidence interval;
- mRS=
- modified Rankin Scale
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
The byline for this article was updated on February 07, 2022
Editorial, page 987
- Received October 15, 2018.
- Accepted in final form July 22, 2019.
- © 2019 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
- Author response: The dimension of preventable stroke in a large representative patient cohort
- Christian Boehme, Resident Neurologist, Department of Neurology, Medical University of Innsbruck
- Thomas Toell, Resident Neurologist, Department of Neurology, Medical University of Innsbruck
- Michael Knoflach, Neurologist, Department of Neurology, Medical University of Innsbruck
- Stefan Kiechl, Neurologist, Chair, Department of Neurology, Medical University of Innsbruck
Submitted June 24, 2020 - Author response: The dimension of preventable stroke in a large representative patient cohort
- Christian Boehme, Resident Neurologist, Department of Neurology, Medical University of Innsbruck
- Lukas Mayer, Resident Neurologist, Department of Neurology, Medical University of Innsbruck
- Johann Willeit, Neurologist, Department of Neurology, Medical University of Innsbruck
- Stefan Kiechl, Neurologist, Chair, Department of Neurology, Medical University of Innsbruck
Submitted June 24, 2020 - Reader Response: The dimension of preventable stroke in a large representative patient cohort
- Larry B. Goldstein, Ruth L Works Professor and Chair, Dept. of Neurology, University of Kentucky
Submitted December 16, 2019 - Reader response: The dimension of preventable stroke in a large representative patient cohort
- Dearbhla M. Kelly, Clinical Research Fellow, Wolfson Centre for the Prevention of Stroke and Dementia, Nuffield Department of Clinical Neurosciences, University of Oxford
Submitted November 13, 2019
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Ann Yeh and Dr. Daniela Castillo Villagrán
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Article
Statin therapy in acute cardioembolic stroke with no guidance-based indicationHong-Kyun Park, Ji Sung Lee, Keun-Sik Hong et al.Neurology, April 09, 2020 -
Articles
Statin therapy after first stroke reduces 10-year stroke recurrence and improves survivalH. J. Milionis, S. Giannopoulos, M. Kosmidou et al.Neurology, May 26, 2009 -
Articles
Risk factors, outcomes, and stroke subtypes for ischemic strokeRalph L. Sacco et al.Neurology, November 01, 1997 -
Article
CHADS2, CHA2DS2-VASc, and long-term stroke outcome in patients without atrial fibrillationGeorge Ntaios, Gregory Y.H. Lip, Konstantinos Makaritsis et al.Neurology, February 13, 2013